The 2022 American Academy of Dermatology Annual Meeting, the group’s first live meeting in two years, featured exciting new launches in the energy-based device and cosmeceutical spaces, along with multiple presentations on new and emerging uses of available medications to treat a growing list of dermatologic diseases.
In this post-conference wrap-up report, we summarize select presentations that we deemed especially noteworthy at the annual meeting this year. Click on the image above to view the highlights from our team of analysts.
The 2022 American Academy of Dermatology Annual Meeting, the group’s first live meeting in two years, featured exciting new launches in the energy-based device and cosmeceutical spaces, along with multiple presentations on new and emerging uses of available medications to treat a growing list of dermatologic diseases.
In this post-conference wrap-up report, we summarize select presentations that we deemed especially noteworthy at the annual meeting this year. Click on the image above to view the highlights from our team of analysts.
The 2022 American Academy of Dermatology Annual Meeting, the group’s first live meeting in two years, featured exciting new launches in the energy-based device and cosmeceutical spaces, along with multiple presentations on new and emerging uses of available medications to treat a growing list of dermatologic diseases.
In this post-conference wrap-up report, we summarize select presentations that we deemed especially noteworthy at the annual meeting this year. Click on the image above to view the highlights from our team of analysts.
The 2022 American Academy of Dermatology Annual Meeting, the group’s first live meeting in two years, featured exciting new launches in the energy-based device and cosmeceutical spaces, along with multiple presentations on new and emerging uses of available medications to treat a growing list of dermatologic diseases.
In this post-conference wrap-up report, we summarize select presentations that we deemed especially noteworthy at the annual meeting this year. Click on the image above to view the highlights from our team of analysts.
Orobol from enzyme biotransformation attenuates Dermatophagoides farinae-induced atopic dermatitis-like symptoms in NC/Nga mice - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35355022/
Orobol, a metabolite of genistein, is rare in natural soybean. Several studies have revealed the immune-controlling effects of orobol on inflammatory diseases. Furthermore, a few studies have demonstrated that orobol...
Pre-treatment of orobol decreased the activity of the MAPKs and NF-κB signalling cascade in the TNFα/IFNγ-induced HaCaT cell line. These results suggest that orobol, a natural dietary isoflavone, has therapeutic efficacy for the prevention and treatment of AD.
